February 17th, 2022
•This protocol describes the methodology for non-invasively tracking T cells genetically engineered to express chimeric antigen receptors in vivo with a clinically available platform.
Related Videos
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Copyright © 2024 MyJoVE Corporation. 판권 소유